← Leaderboards
Hossein Khiabanian
Rbhs -Cancer Institute Of New Jersey
$1,928,732
Attributed
$1,928,732
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $642.9K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,928,732 · 1
By mechanism
R01$1,928,732 · 1
Top collaborators
No co-investigators on record.
Most similar at Rbhs -Cancer Institute Of New Jersey
Same institution · by research overlap
- Subhajyoti De$4,216,614
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAdverse EventAftercareAge RelatedArchitectureBiopsy SpecimenBlood SpecimenBreastBreast Cancer PatientCancer PatientCarcinomaCellsChemotherapyClinicClinical DataClinical PracticeClinical SequencingClinical TranslationClonal EvolutionCohortCommunity Clinical Oncology ProgramComprehensive Cancer CenterCore BiopsyAcute
Grant awards (3)
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment$642,910
R01 · FY2021 · CA · contact PI
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment$642,911
R01 · FY2020 · CA · contact PI
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment$642,911
R01 · FY2019 · CA · contact PI